Safetyand pharmacokinetics of the novel bace inhibitor MK-8931 in healthy subjects following single- and multiple-dose administration

Authors
Category Primary study
JournalAlzheimer's and Dementia
Year 2012
This article has no abstract
Epistemonikos ID: 7fcf4c8ede4699d2b6c4df4f9966fba1daec9b6a
First added on: Feb 05, 2025